Esprinet SpA (MIL:PRT) Research & Development: €0 Mil (TTM As of Mar. 2026)


MIL:PRT Esprinet SpA MIL:PRT
66 GF Score
Price €6.59
GF Value €5.78
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Esprinet SpA Research & Development?

Esprinet SpA MIL:PRT -0.23% 66 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates MIL:PRT with a GF Score™ of 66/100 and a GF Value™ of €5.78 (Modestly Overvalued). The stock has 9 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Esprinet SpA's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Esprinet SpA  (MIL:PRT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Esprinet SpA Research & Development Related Terms

Esprinet SpA Research & Development Historical Data

* Premium members only.

The historical data trend for Esprinet SpA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Esprinet SpA Research & Development Chart

Esprinet SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Esprinet SpA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MIL:PRT
66GF Score
Esprinet SpA MIL:PRT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Esprinet SpA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Esprinet SpA (MIL:PRT) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Esprinet SpA and its competitors.
Is Esprinet SpA's Research & Development too high?
Esprinet SpA's current Research & Development is €0 Mil. Overall, Esprinet SpA has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Esprinet SpA's Research & Development compare to SNX and ARW?
Esprinet SpA's Research & Development of €0 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Hardware company?
A good Research & Development depends on the Hardware industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Esprinet SpA and its competitors. Esprinet SpA's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Esprinet SpA stock overvalued right now?
Based on GuruFocus' analysis, Esprinet SpA (MIL:PRT) is currently considered Modestly Overvalued. The stock's GF Value™ is €5.78, compared to a current price of €6.59 — trading 13.9% above its estimated fair value. The current Research & Development is €0 Mil. Esprinet SpA's overall GF Score™ is 66/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Esprinet SpA (MIL:PRT), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Esprinet SpA (MIL:PRT) Overvalued in 2026?

Based on GuruFocus' analysis, Esprinet SpA stock appears to be overvalued. The current stock price of €6.59 is trading 13.9% above its estimated GF Value™ of €5.78. GuruFocus considers Esprinet SpA to be Modestly Overvalued.

Key valuation signals for MIL:PRT:

  • Research & Development: €0 Mil
  • GF Value™: €5.78 vs. price of €6.59 (13.9% above fair value)
  • GF Score™: 66/100 with 9 warning signs

No single metric tells the full story. See the MIL:PRT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Esprinet SpA Business Description

Other Exchanges 0NFS:UKEP4A:Germany
Address Via Energy Park, 20, Vimercate, ITA, 20871
Esprinet SpA is engaged in the wholesale distribution of IT and consumer electronics in Italy and Spain. It's especially focused on delivering technology to resellers, mainly addressing the small-to-midsize businesses (SMB). The main activity is the wholesale distribution of IT products (hardware, software, and services) and consumer electronics, aimed at retailers oriented towards both consumer and business end-users. The company operates in Europe from Italy, Spain, Portugal, the Netherlands, and Ireland, and outside Europe, from Morocco, in the business-to-business (B2B) distribution of Information Technology (IT) and consumer electronics.
66GF Score

Get the complete analysis for MIL:PRT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.59
Price
€5.78
GF Value